The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of oligometastatic disease on survival in ER positive breast cancer: A population-based analysis.
 
Nathalie LeVasseur
Consulting or Advisory Role - Lilly; Novartis Canada Pharmaceuticals Inc; Pfizer; TerSera
Research Funding - Abbvie; Genomic Health International
 
Kaylie Willemsma
No Relationships to Disclose
 
Caroline A. Lohrisch
No Relationships to Disclose
 
Nafisha Lalani
No Relationships to Disclose
 
Stephen K. L. Chia
Consulting or Advisory Role - Novartis Canada Pharmaceuticals Inc
Research Funding - Celgene; Genentech; Genomic Health International; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Puma Biotechnology; Roche; Sanofi
 
Mitchell Liu
No Relationships to Disclose
 
Karen A. Gelmon
Honoraria - AstraZeneca; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genomic Health; Janssen Oncology; Lilly; Merck; Mylan; NanoString Technologies; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Genentech